课题基金 / 基金详情

Protease Activated Receptor 2 Antagonist In Inflammatory Disease

Protease Activated Receptor 2 Antagonist In Inflammatory Disease
炎症性疾病中蛋白酶激活受体 2 拮抗剂
批准号:
nhmrc : 1000745
负责人:
Prof David Fairlie
金额:
$41.43万
依托单位国家:
澳大利亚
项目类别:
NHMRC Development Grants
财政年份:
2010
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2010-01-01 至 2012-12-31

项目摘要

项目成果

Prof David Fairlie的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The immune response to infection involves a network of proteins that produce an inflammatory response. Sometimes this response is prolonged or uncontrolled and can lead to a large number of inflammatory and other diseases. We have discovered a class of drugs that can bind to a particular protein on the surface of human cells and control this inflammatory response. This property has the potential to treat a wide range of inflammatory and other diseases in humans.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Super-resolution platform to accelerate biological and molecular research
  • 批准号:
    LE240100134
  • 项目类别:
    Linkage Infrastructure, Equipment and Facilities
  • 资助金额:
    $53.09万
  • 财政年份:
    2024
  • 负责人:
    Prof David Fairlie
  • 依托单位:
Compressing small peptides for cell absorption
  • 批准号:
    DP180103244
  • 项目类别:
    Discovery Projects
  • 资助金额:
    $40.43万
  • 财政年份:
    2018
  • 负责人:
    Prof David Fairlie
  • 依托单位:
Combating infectious diseases by harnessing macrophage functions
  • 批准号:
    nhmrc : GNT1125316
  • 项目类别:
    Project Grants
  • 资助金额:
    $68.82万
  • 财政年份:
    2017
  • 负责人:
    Prof David Fairlie
  • 依托单位:
Modulating Protein-Protein Interactions In Disease
  • 批准号:
    nhmrc : GNT1117017
  • 项目类别:
    Research Fellowships
  • 资助金额:
    $86.39万
  • 财政年份:
    2017
  • 负责人:
    Prof David Fairlie
  • 依托单位:
国内基金
海外基金
ASD1(Activated SAM in Darkness1)调控植物暗形态建成中茎尖分生组织活性的分子机制研究
  • 批准号:
    31970824
  • 项目类别:
    面上项目
  • 资助金额:
    60.0万元
  • 批准年份:
    2019
  • 负责人:
    刘西岗
  • 依托单位:
抑素蛋白(prohibitin)1调控蛋白酶激活受体(protease-activated receptor)1内化转运及降解的功能和机制